@inproceedings{inproceedings, title  = {{The utility of minimal residual disease (MRD) assessment in post-first relapse re-induction: results from the BSBMT/UKMF Myeloma X (intensive) Trial}},

 url = {{}},

 year = {{2014}},

 month = {{5}},

 author = {{Owen RG and DeTute DM and Ashcroft AJ and Cairns DA and Fletcher M and Williams C and Cavenagh JD and Snowden JA and Rawstron AC and Parrish C and Morris TC et al}},

 volume = {{165}},

 journal = {{BRITISH JOURNAL OF HAEMATOLOGY}},

 pages = {{65-66}},

 note = {{Accessed on 2024/12/22}}}